Published in Arch Dermatol Res on November 01, 1997
TGF-beta is specifically expressed in human dermal papilla cells and modulates hair folliculogenesis. J Cell Mol Med (2009) 0.85
Dermal papilla cells induce keratinocyte tubulogenesis in culture. Histochem Cell Biol (2010) 0.84
Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia. J Invest Dermatol (2015) 0.81
Controllable production of transplantable adult human high-passage dermal papilla spheroids using 3D matrigel culture. Tissue Eng Part A (2014) 0.78
Therapeutic role of human hepatocyte growth factor (HGF) in treating hair loss. PeerJ (2016) 0.75
Other functions, other genes: alternative activation of antigen-presenting cells. Immunity (1999) 4.15
Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol (1998) 3.18
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene (1996) 2.73
The role of beta7 integrins in CD8 T cell trafficking during an antiviral immune response. J Exp Med (1999) 2.62
Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke (2003) 2.44
[Definition, classification and diagnosis of fibromyalgia syndrome]. Schmerz (2008) 2.38
Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol (1998) 2.17
Alternative versus classical activation of macrophages. Pathobiology (1999) 2.14
Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma. Lancet (1997) 1.98
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med (2013) 1.96
Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol (2001) 1.86
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology (2010) 1.80
Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res (1997) 1.73
TLR7 and TLR8 as targets in cancer therapy. Oncogene (2008) 1.72
Imiquimod: mode of action. Br J Dermatol (2007) 1.70
The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol (2001) 1.67
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke (2004) 1.66
EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol (2010) 1.63
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke (2000) 1.55
CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (2012) 1.55
Maintaining skin integrity in the aged: a systematic review. Br J Dermatol (2013) 1.47
Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol (1992) 1.47
Buschke-Ollendorff syndrome--differential diagnosis of disseminated connective tissue lesions. Eur J Dermatol (2001) 1.47
Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology (1997) 1.44
Basal-cell adhesion molecule (B-CAM) is induced in epithelial skin tumors and inflammatory epidermis, and is expressed at cell-cell and cell-substrate contact sites. J Invest Dermatol (2000) 1.44
Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol (1999) 1.43
Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J (1997) 1.43
Intravascular coagulation necrosis of the skin associated with cryofibrinogenemia, diabetes mellitus, and cardiolipin autoantibodies. J Am Acad Dermatol (1991) 1.39
Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study. Br J Dermatol (2014) 1.39
Von Willebrand disease caused by compound heterozygosity for p.r854q and p.r760c: diagnostic and therapeutic implications. Haemophilia (2010) 1.39
Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab Invest (1996) 1.38
[Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma]. Hautarzt (1992) 1.38
Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol (1996) 1.38
[Acute generalized exanthematous pustulosis, induced by nystatin]. Hautarzt (1998) 1.38
Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol (1993) 1.36
Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations. Br J Dermatol (2014) 1.36
Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J Invest Dermatol (2000) 1.32
Alterations of cell surfaces as a pathogenetic factor in psoriasis. Possible loss of contact inhibition of growth. Arch Dermatol (1973) 1.31
Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma. Br J Cancer (1998) 1.28
Oral retinoids--present status. Br J Dermatol (1980) 1.26
Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol (1992) 1.25
Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology (1997) 1.24
Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br J Dermatol (1983) 1.24
Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus (1997) 1.23
13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol (2000) 1.21
Role of integrin alphaE(CD103)beta7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J Invest Dermatol (2001) 1.20
Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res (1995) 1.18
Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol (1999) 1.18
Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer (1997) 1.17
Matting of hair: a multifactorial enigma. Dermatology (2000) 1.16
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Oncogene (2007) 1.15
Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer (1995) 1.15
Dermal and epidermal types of erythema multiforme. A histopathologic study of 24 cases. Arch Dermatol (1974) 1.15
Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis. Arch Dermatol Res (1996) 1.13
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer (1995) 1.12
Hair follicles--an efficient storage and penetration pathway for topically applied substances. Summary of recent results obtained at the Center of Experimental and Applied Cutaneous Physiology, Charité -Universitätsmedizin Berlin, Germany. Skin Pharmacol Physiol (2008) 1.12
Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri. Stroke (2001) 1.12
Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro. Neuroscience (2008) 1.11
Kaposi's sarcoma is an important risk factor for survival in HIV-infected patients independent of CD4+ cell count. AIDS (1999) 1.09
Hair destroying growth of Corynebacterium tenuis in the so-called trichomycosis axillaris. New findings from scanning electron microscopy. Arch Dermatol (1971) 1.09
The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol (2004) 1.08
Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett (2000) 1.08
Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. AIDS (1997) 1.07
The plasma unit membrane. Membrane mediated growth control and its failure in psoriasis. Br J Dermatol (1977) 1.07
Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci Lett (2001) 1.06
Fracture of the lateral process of the talus in snowboarders. J Bone Joint Surg Br (2007) 1.06
Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine. J Biol Chem (1998) 1.06
Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol (2001) 1.05
Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol (2004) 1.05
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol (2006) 1.04
Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol (1993) 1.04
Small-fiber neuropathy in patients with ALS. Neurology (2011) 1.04
Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res (2000) 1.02
Desmin and actin associated with cytoplasmic bodies in skeletal muscle fibers: immunocytochemical and fine structural studies, with a note on unusual 18- to 20-nm filaments. Acta Neuropathol (1990) 1.02
Non-specific lymphocyte transformation in vitro by nickel acetate. A possible source of errors in lymphocyte transformation test (LLT). J Invest Dermatol (1970) 1.02
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol (1990) 1.02
Small fibre neuropathy in sarcoidosis. Lancet (2002) 1.01
Contralateral cytokine gene induction after peripheral nerve lesions: dependence on the mode of injury and NMDA receptor signaling. Brain Res Mol Brain Res (2005) 1.01
[Acquired reactive perforating dermatosis. Successful treatment with allopurinol in 2 cases]. Hautarzt (1999) 1.01
[Beneficial effect of oral retinoid in psoriatic hyperproliferation. Autoradiographic studies on involved and non involved skin (author's transl)]. Arch Dermatol Res (1979) 1.00
Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol (1997) 1.00
Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. Am J Dermatopathol (1987) 1.00
[Netherton's syndrome. Ichthyosis-like changes in the skin and trichorrhexis invaginata. Demonstration of pathologically changed cortex keratin in the hair]. Hautarzt (1971) 0.99
An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol (2013) 0.99
Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Apoptosis (2004) 0.99
Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice. J Immunol (2000) 0.99
Electron microscopic study of bullous pemphigoid. Arch Dermatol (1972) 0.99
Degradation of 1,4-dichlorobenzene by Xanthobacter flavus 14p1. Appl Environ Microbiol (1995) 0.99
Ultrastructure and cytochemistry of human cutaneous nerves. With special reference to the ultrastructural localization of the specific and nonspecific cholinesterases in human skin. J Invest Dermatol (1973) 0.98
Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res (1998) 0.98
Ultrastructural evidence suggesting an immunomodulatory activity of oral retinoid. Its effect on dermal components in psoriasis. Br J Dermatol (1981) 0.98